- Home
- ARGX vs NDAQ Comparison
ARGX vs NDAQ Comparison
Compare ARGX & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- NDAQ
- Stock Information
- Founded
- ARGX 2008
- NDAQ 1971
- Country
- ARGX Netherlands
- NDAQ United States
- Employees
- ARGX N/A
- NDAQ N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- NDAQ Investment Bankers/Brokers/Service
- Sector
- ARGX Health Care
- NDAQ Finance
- Exchange
- ARGX Nasdaq
- NDAQ Nasdaq
- Market Cap
- ARGX 37.3B
- NDAQ 43.8B
- IPO Year
- ARGX 2017
- NDAQ 2002
- Fundamental
- Price
- ARGX $623.82
- NDAQ $77.70
- Analyst Decision
- ARGX Strong Buy
- NDAQ Buy
- Analyst Count
- ARGX 20
- NDAQ 16
- Target Price
- ARGX $634.50
- NDAQ $82.40
- AVG Volume (30 Days)
- ARGX 290.3K
- NDAQ 2.8M
- Earning Date
- ARGX 10-31-2024
- NDAQ 01-29-2025
- Dividend Yield
- ARGX N/A
- NDAQ 1.24%
- EPS Growth
- ARGX N/A
- NDAQ N/A
- EPS
- ARGX N/A
- NDAQ 1.68
- Revenue
- ARGX $1,908,659,000.00
- NDAQ $7,017,000,000.00
- Revenue This Year
- ARGX $61.99
- NDAQ N/A
- Revenue Next Year
- ARGX $42.48
- NDAQ $7.54
- P/E Ratio
- ARGX N/A
- NDAQ $46.21
- Revenue Growth
- ARGX 85.56
- NDAQ 16.97
- 52 Week Low
- ARGX $349.86
- NDAQ $54.90
- 52 Week High
- ARGX $644.97
- NDAQ $83.77
- Technical
- Relative Strength Index (RSI)
- ARGX 58.04
- NDAQ 40.55
- Support Level
- ARGX $613.95
- NDAQ $79.95
- Resistance Level
- ARGX $644.97
- NDAQ $80.08
- Average True Range (ATR)
- ARGX 14.33
- NDAQ 1.24
- MACD
- ARGX -0.42
- NDAQ -0.64
- Stochastic Oscillator
- ARGX 50.28
- NDAQ 13.29
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About NDAQ Nasdaq Inc.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.